Clinical Trial Agreement | 24-Apr-2024 | 15:36 | RNS |
Application for Listing & Total Voting Rights | 03-Apr-2024 | 17:00 | RNS |
NICE recommends the Genedrive CYP2C19-ID Kit | 03-Apr-2024 | 07:00 | RNS |
Half-year Report | 28-Mar-2024 | 07:00 | RNS |
Application for Listing & Total Voting Rights | 19-Mar-2024 | 15:53 | RNS |
Receipt of R&D tax credit | 15-Mar-2024 | 12:30 | RNS |
NICE Early Value Assessment update | 19-Feb-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 06-Feb-2024 | 14:03 | RNS |
Total Voting Rights | 02-Feb-2024 | 15:35 | RNS |
Total Voting Rights | 19-Jan-2024 | 16:14 | RNS |
Total Voting Rights | 15-Jan-2024 | 15:21 | RNS |
Total Voting Rights | 10-Jan-2024 | 07:00 | RNS |
Equity Prepayment Facility drawdown | 02-Jan-2024 | 07:00 | RNS |
Result of AGM | 29-Dec-2023 | 11:44 | RNS |
Total Voting Rights | 20-Dec-2023 | 16:57 | RNS |
Currency | UK Pounds |
Share Price | 5.15p |
Change Today | 0.025p |
% Change | 0.49 % |
52 Week High | 22.25 |
52 Week Low | 3.13 |
Volume | 384,843 |
Shares Issued | 143.14m |
Market Cap | £7.37m |
Beta | 0.06 |
RiskGrade | 747 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:55 | 11,150 @ 4.99p |
11:49 | 190,000 @ 4.99p |
11:36 | 39 @ 5.05p |
11:14 | 50,826 @ 4.90p |
11:07 | 7,433 @ 4.81p |
You are here: research